Liver cancer cases Generally Because Hepatitis Diseases

Do not assume paltry disease hepatitis! Most cases of liver cancer (hepatocellular carcinoma / HCC), or around 40-50 percent are caused by Hepatitis B, and the rest by the Hepatitis C (30-40 percent) and non-factor for hepatitis B and C as perlemakan hearts (10-20 percent) .

Head of the National Hepatitis Working Group, Prof. Dr. Ali Sulaiman SpPD, KGEH explains, causes liver cancer function of the liver failure and can lead to death.

"The new known if the patient suffered from liver cancer after the disease reach the stadium information," said Ali who is also professor of hepatologi Faculty of Medicine, University of the Philippines.

According to Ali, without proper treatment, liver cancer patients generally do not have a life expectancy of more than two years after diagnosis position.

Liver cancer treatment methods varied, including cutting (reseksi) and transplanting (transplantation), with the injection of ethanol, hemoembolisasi, Radio Frequency Ablation, chemotherapy, and local therapy (molecullar targetted therapy).

In addition, Ali said, there is a drug discovery oral multikinase new Enzyme inhibitor called sorafenib could become an option for patients advanced liver cancer.

In addition to the growth of the number of cancer cells, according to Ali, the drug also works as antiangiogenesis, namely the formation of blood vessels secured the supply needs of cancer cells.

According to Ali, drugs that zero in two parts, namely cell proliferation and angiogenesis, or blood vessel formation. Both major role in the growth of cancer.

"Results of the clinical testing of the use of sorafenib, showed that the use of these drugs can improve the quality of life of patients and slow the development of the disease," said Ali.

However, Ali said, there are side effects due to the use of drugs in the oral cancer patients heart rate information that is diarrhea.